backgroundidentifi
respiratori
pathogen
within
popul
difficult
invas
sampl
collect
nasopharyng
aspir
npa
gener
requir
pcr
technolog
could
allow
noninvas
sampl
method
objectivesevalu
util
noninvas
sampl
collect
use
anterior
nare
swab
facial
tissu
respiratori
viru
detect
multiplex
pcr
studi
designchildren
age
month
year
evalu
pediatr
emerg
depart
respiratori
symptom
swab
facial
tissu
npa
sampl
collect
sampl
test
respiratori
virus
multiplex
pcr
viral
detect
rate
calcul
collect
method
sensit
specif
swab
facial
tissu
calcul
use
npa
gold
standard
sampl
children
evalu
swabnpa
pair
facial
tissuenpa
pair
npa
swab
tissu
sampl
posit
viru
respiratori
syncyti
viru
rsv
human
rhinoviru
hrv
common
overal
swab
posit
viru
infect
facial
tissu
posit
sensit
rang
swab
tissu
sensit
highest
ethic
approv
institut
review
board
intermountain
healthcar
univers
utah
approv
studi
parent
studi
subject
provid
inform
consent
sampl
diagnost
test
children
older
year
provid
assent
compet
interest
lm
mr
ch
mp
employe
idaho
technolog
inc
ajb
maa
jad
clb
collabor
idaho
technolog
inc
sever
nih
cdcfund
project
see
fund
rsv
swab
tissu
specif
virus
except
hrv
collect
method
conclusionssensit
anterior
nare
swab
facial
tissu
detect
respiratori
virus
multiplex
pcr
vari
viru
type
given
simplic
specif
noninvas
sampl
pcr
test
may
use
conduct
epidemiolog
surveil
studi
set
invas
test
impract
feasibl
keyword
respiratori
viru
viral
diagnost
molecular
diagnost
pediatr
upper
respiratori
infect
polymeras
chain
reaction
background
respiratori
tract
infect
common
reason
medic
visit
hospit
admiss
childhood
influenza
viru
respiratori
syncyti
viru
rsv
frequent
implic
howev
mani
virus
recent
recogn
import
diagnost
test
respiratori
virus
usual
perform
hospit
set
test
serv
sever
function
includ
facilit
patient
cohort
initi
antivir
therapi
contain
nosocomi
outbreak
decreas
use
ancillari
test
antibiot
case
respiratori
sampl
collect
invas
method
nasopharyng
swab
nasopharyng
aspir
npa
diagnost
perform
use
immunofluoresc
andor
culturebas
method
increas
sensit
demonstr
polymeras
chain
reaction
pcr
use
pcr
diagnost
hospit
increas
diagnost
test
respiratori
virus
also
import
surveil
epidemiolog
studi
perform
hospit
commun
set
throughout
year
multipl
respiratori
virus
cocircul
caus
similar
clinic
syndrom
distinguish
without
diagnost
test
recent
studi
nonpharmaceut
intervent
prevent
spread
influenza
highlight
need
largescal
communitybas
epidemiolog
data
includ
specif
laboratoryconfirm
diagnosi
pcrbase
method
enabl
investig
perform
familybas
studi
viral
preval
commun
invas
respiratori
sampl
collect
method
respiratori
test
signific
limit
commun
studi
perform
nasopharyng
aspir
swab
test
stress
lead
reluct
among
children
parent
particip
studi
particularli
repeat
test
requir
base
higher
sensit
pcr
hypothes
respiratori
virus
could
detect
sampl
collect
noninvas
method
might
accept
children
anterior
nare
swab
facial
tissu
studi
investig
use
anterior
nare
swab
collect
sampl
detect
respiratori
virus
studi
investig
use
facial
tissu
publish
object
evalu
perform
noninvas
sampl
collect
use
anterior
nare
swab
facial
tissu
respiratori
viral
detect
multiplex
pcr
institut
review
board
intermountain
healthcar
univers
utah
approv
studi
parent
studi
subject
provid
inform
consent
sampl
test
children
older
year
provid
assent
primari
children
medic
center
pcmc
salt
lake
citi
ut
bed
tertiarycar
children
hospit
sampl
collect
infant
children
age
month
year
undergo
evalu
respiratori
ill
emerg
depart
ed
studi
conduct
winter
respiratori
season
englishspeak
famili
noncriticallyil
children
evalu
respiratori
viral
test
npa
part
routin
care
elig
consent
obtain
train
research
assist
particip
parent
use
nylonflock
swab
copan
diagnost
inc
cm
tip
cm
shaft
collect
specimen
particip
anterior
nare
parent
particip
elect
collect
specimen
research
assist
gave
brief
standard
instruct
use
anterior
nare
swab
andor
facial
tissu
sampl
collect
research
assist
place
swab
ml
cryovial
transport
next
particip
blew
nose
nose
wipe
white
facial
tissu
kirkland
brand
without
scent
lotion
antimicrobi
addit
research
assist
select
approxim
cm
piec
facial
tissu
appear
soil
nasal
secret
near
center
tissu
appli
nare
research
assist
use
glove
hand
tear
portion
tissu
insert
ml
transport
cryovial
transport
medium
use
swab
facial
tissu
valid
studi
show
degrad
rna
storag
day
data
shown
sampl
store
pcmc
microbiolog
laboratori
transport
standard
cooler
idaho
technolog
inc
iti
within
day
npa
sampl
collect
nurs
respiratori
therapist
accord
ed
protocol
sampl
transport
pcmc
microbiolog
laboratori
aliquot
obtain
process
store
c
within
hour
receipt
laboratori
month
aliquot
transfer
iti
cooler
dri
ice
upon
arriv
swab
facial
tissu
npa
sampl
store
c
pcrtest
conduct
month
collect
npa
anterior
nare
swab
facial
tissu
sampl
test
respiratori
virus
use
iti
respiratori
panel
fda
approv
multiplex
pcr
panel
includ
assay
adenoviru
av
influenza
influenza
b
parainfluenza
viru
type
piv
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
human
rhinoviru
hrv
coronavirus
cv
includ
studi
research
version
pouch
use
also
contain
assay
cv
cv
prior
introduct
filmarray
specimen
mix
denatur
buffer
facial
tissu
anterior
nare
swab
sampl
involv
ad
buffer
cryovial
contain
facial
tissu
swab
cryovial
vortex
mixtur
aspir
syring
sampl
inject
filmarray
sampl
contain
pouch
use
blunt
tip
cannula
filmarray
close
system
combin
nucleic
acid
extract
clinic
specimen
nest
multiplex
pcr
post
pcr
analysi
introduct
filmarray
pouch
cell
virus
within
sampl
lyse
use
ceram
bead
nucleic
acid
extract
use
magnet
bead
use
templat
firststag
multiplex
pcr
limit
number
firststag
amplif
cycl
amplif
product
dilut
buffer
move
array
microlit
well
secondstag
singleplex
nest
pcr
perform
assay
within
stage
nest
pcr
target
specif
respiratori
pathogen
amplif
product
gener
second
stage
pcr
detect
specif
melt
profil
use
lcgreen
idaho
technolog
proprietari
melt
dye
due
close
natur
filmarray
pouch
contain
pcr
contamin
risk
low
howev
neg
control
run
includ
sampletyp
proport
sampl
posit
viru
calcul
proport
posit
sampl
compar
children
age
year
younger
children
year
children
year
older
use
cochranarmitag
trend
test
next
detect
rate
determin
viru
sampletyp
influenza
piv
cv
type
group
analys
viru
detect
rate
calcul
divid
number
posit
test
per
sampletyp
total
number
posit
test
viru
overal
test
accuraci
calcul
compar
result
pcr
test
pair
anterior
nare
swabnpa
sampl
pair
facial
tissuenpa
sampl
anterior
nare
swab
facial
tissuenpa
pair
complet
match
identifi
viru
detect
npa
also
detect
pair
swab
facial
tissu
npa
pair
swab
facial
tissu
neg
virus
sensit
specif
anterior
nare
swab
facial
tissu
calcul
viru
use
pair
swabnpa
tissuenpa
data
npa
use
gold
standard
viru
test
posit
identifi
swab
facial
tissu
sampl
posit
viru
true
posit
identifi
pair
npa
sampl
also
posit
viru
sensit
calcul
test
posit
divid
true
posit
specif
pcr
test
consid
neg
identifi
particular
viru
even
identifi
differ
viru
specif
calcul
test
neg
swab
facial
tissu
divid
true
neg
npa
viru
ninetyf
percent
confid
interv
calcul
ninetyf
children
particip
studi
median
age
year
rang
month
year
major
year
younger
year
older
total
sampl
collect
least
one
viru
identifi
pcr
npa
anterior
nare
swab
facial
tissu
sampl
tabl
one
viru
detect
npa
anterior
nare
swab
facial
tissu
sampl
proport
posit
sampl
among
older
children
appear
slightli
higher
proport
posit
sampl
among
younger
children
anterior
nare
swab
facial
tissu
sampletyp
tabl
differ
statist
signific
rsv
hrv
frequent
detect
virus
tabl
virus
npa
highest
detect
rate
although
anterior
nare
swab
detect
rate
equal
npa
influenza
virus
rsv
higher
cv
case
influenza
cv
hrv
piv
rsv
hmpv
detect
anterior
nare
swab
detect
rate
facial
tissu
sampl
lower
npa
swab
virus
higher
swab
adenovirus
av
case
influenza
piv
rsv
hmpv
detect
facial
tissu
sampl
pair
data
avail
anterior
nare
swabnpa
pair
facial
tissuenpa
pair
anterior
nare
swab
result
complet
match
npa
result
facial
tissu
result
complet
match
npa
result
test
accuraci
also
calcul
use
data
particip
whose
npa
sampl
posit
singl
viru
analysi
anterior
nare
swab
result
complet
match
npa
result
facial
tissu
result
complet
match
npa
result
tabl
show
sensit
specif
anterior
nare
swab
facial
tissu
compar
npa
gold
standard
viru
anterior
nare
swab
show
high
sensit
influenza
hmpv
rsv
facial
tissu
also
show
high
sensit
rsv
specif
noninvas
sampletyp
virus
except
hrv
data
demonstr
noninvas
method
collect
respiratori
sampl
use
identifi
respiratori
virus
multiplex
pcr
test
detect
rate
virus
rsv
use
npa
gold
standard
sensit
noninvas
method
rang
individu
virus
studi
viral
detect
av
low
detect
rate
gener
anterior
nare
swab
higher
detect
rate
higher
sensit
facial
tissu
sampl
type
specif
virus
except
hrv
data
suggest
investig
requir
noninvas
collect
respiratori
sampl
viral
test
multiplex
pcr
may
use
conduct
surveil
epidemiolog
studi
commun
set
invas
test
impract
feasibl
studi
investig
use
anterior
nare
swab
detect
respiratori
virus
use
antigen
detect
viral
cultur
pcr
sampl
collect
anterior
nare
flock
swab
shown
compar
collect
npa
although
studi
report
difficulti
detect
rsv
swab
includ
one
studi
detect
cultur
one
pcr
culturebas
studi
labil
rsv
hypothes
factor
decreas
sensit
swab
studi
sensit
swab
facial
tissu
sampl
highest
rsv
knowledg
studi
look
use
facial
tissu
sampl
collect
method
detect
respiratori
virus
children
facial
tissu
inexpens
readili
avail
experi
children
gener
accept
without
signific
distress
method
could
particularli
benefici
use
popul
surveil
allow
selfcollect
larg
number
individu
quickli
set
public
health
emerg
studi
larg
group
repeat
sampl
involv
facial
tissu
might
practic
accept
method
obtain
specimen
sensit
facial
tissu
lower
swab
adequ
sampl
type
individu
diagnost
howev
specif
viral
detect
may
make
appropri
commun
surveil
detect
posit
like
indic
pathogen
popul
studi
sensit
sampl
collect
method
vari
viru
type
number
posit
specimen
mani
virus
low
comparison
could
compar
rsv
hrv
sensit
detect
rsv
anterior
nare
swab
facial
tissu
hrv
reason
unclear
could
due
viru
symptomrel
factor
would
requir
investig
high
specif
detect
virus
crucial
surveil
provid
confid
detect
viru
circul
popul
current
method
influenza
surveil
virusspecif
perform
exampl
school
absente
data
sentinel
clinic
influenzalik
ill
ili
report
absente
due
number
factor
unrel
influenza
specif
ili
cultureproven
influenza
shown
rang
use
noninvas
sampl
method
combin
molecular
detect
could
offer
potenti
broaden
populationbas
test
possibl
signific
improv
data
studi
infecti
pathogen
noninvas
collect
method
combin
molecular
detect
improv
epidemiolog
understand
cost
molecular
test
could
consid
prohibit
use
surveil
set
howev
sampl
strategi
involv
pool
test
may
result
signific
save
studi
warrant
sever
limit
studi
primari
limit
sampl
size
particip
provid
sampl
number
viru
detect
small
studi
design
determin
noninferior
swab
tissu
individu
diagnost
compar
npa
age
rang
particip
bias
toward
children
younger
year
may
higher
respiratori
viral
load
older
children
therefor
report
viru
detect
rate
may
higher
would
found
older
children
addit
young
age
particip
may
made
difficult
evalu
sampl
collect
facial
tissu
small
children
blow
nose
adequ
expel
nasal
secret
one
brand
facial
tissu
test
possibl
other
perform
manner
recoveri
virus
facial
tissu
sampl
particular
may
affect
lack
precis
sampl
collect
transfer
cryovial
howev
believ
result
still
use
method
reflect
like
occur
commun
epidemiolog
studi
sampletyp
might
use
final
children
test
ed
thought
suffici
ill
viral
test
order
children
may
higher
respiratori
viral
load
make
detect
easier
surveil
healthi
children
may
low
viral
load
noninvas
test
may
perform
well
overal
anterior
nare
swab
facial
tissu
promis
tool
noninvas
diagnost
test
respiratori
virus
certain
circumst
appropri
patient
care
use
noninvas
respiratori
sampl
may
prove
valuabl
epidemiolog
surveil
studi
commun
set
respiratori
diagnost
limit
proport
posit
sampl
one
virus
detect
sampl
type
age
group
age
group
year
younger
though
year
year
older
tabl
viru
detect
rate
collect
method
number
detect
total
viru
av
cv
iv
hrv
hmpv
piv
